478 related articles for article (PubMed ID: 19694687)
1. Using botulinum toxin for pelvic indications in women.
Rao A; Abbott J
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):352-7. PubMed ID: 19694687
[TBL] [Abstract][Full Text] [Related]
2. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems?
Abbott J
J Minim Invasive Gynecol; 2009; 16(2):130-5. PubMed ID: 19167273
[TBL] [Abstract][Full Text] [Related]
3. Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain.
Abbott J
Toxicon; 2009 Oct; 54(5):647-53. PubMed ID: 19264089
[TBL] [Abstract][Full Text] [Related]
4. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
Schmid DM; Roy S; Sulser T; Scheiner D
BJU Int; 2008 Jul; 102 Suppl 1():7-10. PubMed ID: 18665972
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles.
Jarvis SK; Abbott JA; Lenart MB; Steensma A; Vancaillie TG
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):46-50. PubMed ID: 15089868
[TBL] [Abstract][Full Text] [Related]
6. Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?
da Silva CM; Cruz F
Curr Opin Urol; 2009 Jul; 19(4):347-52. PubMed ID: 19444121
[TBL] [Abstract][Full Text] [Related]
7. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles.
Thomson AJ; Jarvis SK; Lenart M; Abbott JA; Vancaillie TG
BJOG; 2005 Feb; 112(2):247-9. PubMed ID: 15663593
[No Abstract] [Full Text] [Related]
8. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
Pannek J; Göcking K; Bersch U
BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
Kuo HC
Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
[TBL] [Abstract][Full Text] [Related]
13. [Overactive pelvic floor syndrome].
Rognlid M; Lindsetmo RO
Tidsskr Nor Laegeforen; 2010 Oct; 130(20):2016-20. PubMed ID: 20967040
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin A for the treatment of chronic anal fissure.
Brisinda G; Cadeddu F; Mazzeo P; Maria G
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):219-28. PubMed ID: 19072412
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin injection therapy in the management of lower urinary tract dysfunction.
Patel AK; Chapple CR
Int J Clin Pract Suppl; 2006 Dec; (151):1-7. PubMed ID: 17169004
[TBL] [Abstract][Full Text] [Related]
16. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
[TBL] [Abstract][Full Text] [Related]
17. Methodological approaches to botulinum toxin for the treatment of chronic pelvic pain, vaginismus, and vulvar pain disorders.
Karp BI; Tandon H; Vigil D; Stratton P
Int Urogynecol J; 2019 Jul; 30(7):1071-1081. PubMed ID: 30617506
[TBL] [Abstract][Full Text] [Related]
18. Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data.
Brown CS; Glazer HI; Vogt V; Menkes D; Bachmann G
J Reprod Med; 2006 Aug; 51(8):635-41. PubMed ID: 16967634
[TBL] [Abstract][Full Text] [Related]
19. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A (Botox) injection into muscles of pelvic floor as a treatment for persistent pelvic pain secondary to pelvic floor muscular spasm: A pilot study.
Mooney SS; Readman E; Hiscock RJ; Francis A; Fraser E; Ellett L
Aust N Z J Obstet Gynaecol; 2021 Oct; 61(5):777-784. PubMed ID: 34128537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
